# End-to-End Everywhere implementation and testing

The owner directs the agent to implement applicable security controls, execute the tests, fix findings, and continue dependency-ready development. A human will repeat critical tests later. Pending human review, external audit budgets, and certification are never prerequisites for agent work or release. Real failures are repaired, not relabeled as success.

## Records and standard basis

`security/e2eesa-status.json` follows the shared three-stage record. All full-product stages begin incomplete because LM-001 is only the foundation. Per-PR checks can pass while complete-product testing remains incomplete. Independent review remains explicitly pending, with no blocking `externalPrerequisites` added to the PR plan.

The upstream development basis is pinned to `d916938cb6b0e6569edfde88555984ddacb96021` in `neophilism/End-To-End-Everywhere-Security-Architecture-Standard`. It is a tracking/assessment basis, not certification. Existing reviewed protocol and profile decisions must be preserved; any later profile adoption needs an explicit source-bound decision.

The checked-in upstream status validator guards unsupported completion claims. Run `python3 scripts/validate_e2eesa_status.py`; use `--fingerprint` on a clean committed source for later evidence-only updates. The six complete-product gate categories are unit, adversarial, fuzz, secret-scan, dependency-scan, and static-analysis. Retain exact tool/configuration digests, reports, timestamps, and assessed source. Include real applicable provider, browser, recovery, permission, and end-to-end tests. Do not mark the aggregate stage complete from foundation tests.

## Initial boundaries and follow-through

| Boundary | Control and test responsibility | Planned units |
| --- | --- | --- |
| Untrusted source bytes | Archive/page/depth limits, isolated parsing, XML entity rejection, XSS and SSRF tests | LM-009–011, LM-044, LM-056 |
| Private authoring and storage | Authenticated roles, tenant isolation, revision checks, private caches, deletion/export behavior | LM-042–045, LM-047, LM-049 |
| Public publication | Explicit authorized publication, source integrity, immutable packages, withdrawal/correction, rollback | LM-004, LM-047, LM-049, LM-054, LM-057 |
| Simulation and visitor input | Typed operators, bounded computation, reproducible replay, hostile input and parity tests | LM-019–030, LM-037, LM-051, LM-055–056 |
| Optional AI/provider operations | Server-only credentials, explicit processing disclosure, structured candidates, budgets, timeout/kill switch | LM-046, LM-048 |
| Operational reliability | Backup/restore, job leases, migration rollback, incident procedures, real deployment evidence | LM-046, LM-052–054, LM-060 |
| Supply chain and source | Pinned CI actions, reviewed dependency locks, secret and dependency scanning, reproducible builds | LM-001–002, LM-056 |

The inventory is a discovery record, not a reviewed complete assessment. Planned flows include private authoring uploads to authorized server processing/storage, and intentional publication to anonymous browsers. No private E2EE guarantee is made for server-readable authoring data. Public hypothetical scenarios stay local by default. Never accept real legal claims as test data.

## Foundation evidence

LM-001 runs source-preservation, consumer-compatibility, malformed/contradictory registry, dependency-cycle, date, mapping, upstream-integrity, and merge-preflight tests with no third-party packages. The integration check exercises the real command from another directory and proves that an invalid registry makes the command fail. CI executes the same entry point. This is repository-governance coverage, not a substitute for future application/browser/runtime testing.

For every future PR, implement the feature and its negative/error paths, test locally and in CI, inspect findings, fix defects, and verify again. If an optional external service is unavailable, keep its activation disabled and complete provider-free work. Document precisely which real integration remains unverified; never ask a human to perform routine tests instead.
